Legal status · Australia
Is SLU-PP-332 legal in Australia?
No. SLU-PP-332 is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
SLU-PP-332 in Australia at a glance
| Classification | Not approved |
|---|---|
| TGA approval status | Not approved by TGA |
| Evidence level | Preliminary (research strength: Preliminary) |
| Reviewed | Sep 2026 |
Classification and note come from the SLU-PP-332 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
No product containing SLU-PP-332 is approved by TGA for any use in Australia, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.
What SLU-PP-332 is
An experimental 'exercise mimetic' that activates energy-metabolism pathways in animals, with no human data yet.
SLU-PP-332 is an experimental compound that activates estrogen-related receptors (ERRs), master regulators of energy metabolism, effectively mimicking some effects of endurance exercise. In rodent studies it increased endurance and improved metabolic measures without exercise.
Mechanism: Activates estrogen-related receptors (ERRs) to boost mitochondrial energy metabolism, mimicking endurance exercise adaptations.
Regulatory history: Not FDA-approved; experimental
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for SLU-PP-332 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
SLU-PP-332 in other countries
Frequently asked questions
Is SLU-PP-332 legal in Australia?
No. SLU-PP-332 is not an approved medicine in Australia; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.
Can I buy SLU-PP-332 in Australia?
No approved product exists to buy. In Australia SLU-PP-332 is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is SLU-PP-332 TGA approved?
No. In Australia SLU-PP-332 is classified as "Not approved", which is not a TGA marketing approval. For comparison, the US FDA status is: Not FDA-approved; experimental. Evidence level: Preliminary.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for SLU-PP-332 live on its compound profile.
SLU-PP-332 profileThis page is general information about the regulatory status of SLU-PP-332 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.